Small pilot studies that demonstrated a short lived and small improvement in one autism measure, also led to some side effects, including rash only in those receiving suramin
It has also been found to scavenge free radicals and promote cytokine balance, which helps maintain normal inflammatory balance
[PubMed: 12615065] 323
The clinical efficacy is comparable: the OASIS 4 trial showed 13.6% weight loss with the oral 25 mg tablet versus 14.9% for the injection in STEP 1
An insufficient supply of B vitamins, especially vitamin B12, leads to hair loss, according to a study
Regulatory Frameworks and Supply Dynamics: In December 2025, the FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill, which launched in January 2026, significantly expanding accessibility for patients averse to injections [3]